Human Papillomavirus Type 11 L1 Protein Adsorbed
Generic Name: human papillomavirus type 11 l1 protein adsorbed
Dosage form: LIQUID. Active ingredients: HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN (.32 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN (.32 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
Echinacea (angustifolia), Lomatium Dissectum, Hydrastis Canadensis, Sambucus Nigra, Aconitum Napellus, Anas Barbariae, Hepatis Et Cordis Extractum, Arsenicum Album, Belladonna, Bryonia (alba), Eupatorium Perfoliatum, Gelsemium Sempervirens, Lachesis Mutus, Rhus Tox, Pyrogenium, Influenzinum
echinacea (angustifolia), lomatium dissectum, hydrastis canadensis, sambucus nigra, aconitum napellus, anas barbariae, hepatis et cordis extractum, arsenicum album, belladonna, bryonia (alba), eupatorium perfoliatum, gelsemium sempervirens, lachesis mutus, rhus tox, pyrogenium, influenzinum
PURPOSE: Aconitum Napellus - chills,** Anas Barbariae – minor colds,** Arsenicum Album - restlessness,** Belladonna - swelling,** Bryonia - cough,** Eupatorium Perfoliatum - aches,** Gelsemium Sempervirens - headache,** Hydrastis Canadensis – mucus discharge,** Influenzinum - fatigue,** Lachesis Mutus – sore throat,** Pyrogenium - fever,** Rhus Tox - soreness,** Sambucus Nigra – runny nose,** Echinacea - dullness,** Lomatium Dissectum – rash** **Claims based on traditional homeopathic practice,
Cobaltum Nitricum
cobaltum nitricum
Anifrolumab-fnia
anifrolumab-fnia
Type I Interferon Receptor Antagonist [EPC]
11 DESCRIPTION Anifrolumab-fnia is a type I interferon (IFN) receptor antagonist, immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that is produced in mouse myeloma cells (NS0) by recombinant DNA technology. The molecular weight is approximately 148 kDa. SAPHNELO (anifrolumab-fnia) injection is a sterile, preservative‑free, clear to opalescent, colorless to slightly yellow, solution for intravenous use. SAPHNELO contains anifrolumab-fnia at a concentration of 150 mg/mL in a single-dose vial.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.